𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase II study of extended dose temozolomide and thalidomide in previously treated patients with metastatic melanoma

✍ Scribed by Damian A. Laber; Roseline I. Okeke; Carlos Arce-Lara; Beverly S. Taft; Cassandra L. Schonard; Kelly M. McMasters; Goetz H. Kloecker; Donald M. Miller

Publisher
Springer-Verlag
Year
2006
Tongue
English
Weight
255 KB
Volume
132
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Temozolomide plus thalidomide in patient
Temozolomide plus thalidomide in patients with brain metastases from melanoma : A Phase II study
✍ Wen-Jen Hwu; Eric Lis; Jennifer H. Menell; Katherine S. Panageas; Lynne A. Lamb; πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 98 KB

## Abstract ## BACKGROUND Temozolomide plus thalidomide is a promising oral combination regimen for the treatment of metastatic melanoma. The current Phase II study examined the efficacy and safety of this combination in chemotherapy‐naive patients with brain metastases. ## METHODS Patients with

Temozolomide in combination with interfe
Temozolomide in combination with interferon Ξ±-2b in patients with metastatic melanoma : A Phase I dose-escalation study
✍ Sanjiv S. Agarwala; John M. Kirkwood πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 100 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Metastatic melanoma (MM) is associated with a high risk of central nervous system (CNS) metastases, and current chemotherapy does not adequately treat or protect patients with MM against CNS metastases. Therefore, the authors initiated a Phase I study to determine the pha